ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Access to care"

  • Abstract Number: 066 • 2023 Pediatric Rheumatology Symposium

    Telemedicine Use in the Assessment of Juvenile Myositis: A Mixed-Methods Study of an International Healthcare Provider Experience

    Y. Ingrid Goh1, Peter Blier2, Bianca Lang3, Marietta De Guzman4, Julie Fuller5, Kristin Houghton6, Kathryn Cook7, Susan Kim8, Vanessa Carbone1, Heather Tory9, Jo-Anne Marcuz1, Albert Chow10, Liza McCann11, Charalampia Papadopoulou12, Clarissa Pilkington13 and Stacey Tarvin14, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Retired, Amherst, MA, 3Dalhousie University - Halifax, Halifax, NS, Canada, 4Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 5UT Southwestern, Dallas, TX, 6University of British Columbia, Vancouver, BC, Canada, 7Akron Children's Hospital, Akron, OH, 8UCSF Benioff Children's Hospital, San Francisco, CA, 9Connecticut Children's Medical Center, S Glastonbury, CT, 10Loma Linda University, Loma Linda, CA, 11Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 12UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Section Head Infection, Immunology, and Rheumatology, London, United Kingdom, 13Great Ormond Street Hospital, London, United Kingdom, 14Riley Hospital for Children at Indiana University Health, Indianapolis, IN

    Background/Purpose: Care of patients with juvenile myositis (JM) involves complex assessments performed by specialized healthcare providers (HCPs). Restrictions during the COVID-19 pandemic required the rapid…
  • Abstract Number: 085 • 2023 Pediatric Rheumatology Symposium

    Identification of Barriers to Care Experienced by Children with Rheumatic Disease: A Qualitative Study

    Olivia Kwan1, Gloria Garcia2, Kiana Johnson3, Melissa Oliver1, Stacey Tarvin4, Alvaro Tori1, Brandi Stevens1 and Martha Rodriguez4, 1Indiana University, Indianapolis, IN, 2Indiana University School of Medicine, Indianapolis, IN, 3East Tennessee State University, Johnson City, TN, 4Riley Hospital for Children at Indiana University Health, Indianapolis, IN

    Background/Purpose: Pediatric rheumatic diseases are known to have disparities in disease outcomes, but many drivers of these inequities are unknown. Social determinants of health are…
  • Abstract Number: 087 • 2023 Pediatric Rheumatology Symposium

    Delays in Care, Declines in Health, and Food Insecurity in Pediatric Systemic Lupus Erythematosus Patients During the COVID-19 Pandemic

    Rebecca Hetrick1, Maria Pereira2 and Marietta De Guzman3, 1Indiana University School of Medicine, Indianapolis, IN, 2Baylor College of Medicine, Houston, TX, 3Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: The COVID-19 pandemic created dramatic societal disruptions. Social distancing and measures to reduce disease spread rapidly reshaped healthcare delivery. Recognizing the burden of frequent…
  • Abstract Number: 106 • 2023 Pediatric Rheumatology Symposium

    Caregivers’ Perspectives on Barriers to Care in Juvenile Localized and Systemic Scleroderma

    Leigh Stubbs1, Andrew Ferry2, Danielle Guffey1, Christina Loccke3, Erin Moriarty Wade3, Pamela Pour3, Kaveh Ardalan4, Peter Chiraseveenuprapund5, Ingrid Ganske6, Daniel Glaser7, Gloria Higgins8, Nadia Luca9, Katharine Moore10, Vidya Sivaraman11, Katie Stewart1, Natalia Vasquez Canizares12, Raegan Hunt1, Renata Maricevich1, Kathryn Torok13 and Suzanne Li14, 1Baylor College of Medicine, Houston, TX, 2Oregon Health and Science University, Portland, OR, 3n/a, 4Duke University School of Medicine, Durham, NC, 5University of California - San Diego, San Diego, CA, 6Boston Children’s Hospital and Harvard Medical School, Boston, MA, 7Yale University School of Medicine, New Haven, CT, 8Nationwide Childrens Hospital/ The Ohio State University, Columbus, OH, 9University of Calgary, Calgary, AB, Canada, 10University of Colorado / Children's Hospital Colorado, Denver, CO, 11Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 12Children's Hospital at Montefiore, New York, NY, 13University of Pittsburgh, Pittsburgh, PA, 14Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, Hackensack, NJ

    Background/Purpose: Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare rheumatic diseases often associated with severe morbidities. Delays in diagnosis are common, putting children…
  • Abstract Number: 132 • 2023 Pediatric Rheumatology Symposium

    Quality Improvement Lessons in a New Practice

    Farah Shaya, Sharon Bout-Tabaku and Buthaina Al-Adba, Sidra Medicine, Ar-Rayyan, Qatar

    Background/Purpose: Children with Juvenile Idiopathic Arthritis (JIA) have better disease outcomes with current medications available, yet there is variability in these outcomes. Quality improvement (QI)…
  • Abstract Number: 133 • 2023 Pediatric Rheumatology Symposium

    An Interdisciplinary Team Approach to Implementation of a Social Determinants of Health Screener for Pediatric Rheumatology Patients

    Sarah Campbell1, Rosemary Peterson2, Sarah Barrientos3, Elinore Benett3 and Cori Christenholz3, 1University of Texas at Austin Dell Medical School, Austin, TX, 2Dell Medical School at UT Austin, Austin, TX, 3Dell Children's Medical Center Department of Rheumatology, Austin, TX

    Background/Purpose: Adolescents with chronic disease often struggle with the transition from pediatric to adult healthcare leading to poor follow-up and negative health outcomes. Social determinants…
  • Abstract Number: 011 • 2023 Pediatric Rheumatology Symposium

    The Impact of Social Inequities on Presentation of Childhood-Onset Systemic Lupus Erythematosus (cSLE) at a Large Tertiary Center

    Emily Beil1, Eyal Muscal2, Danielle Guffey2, Marietta Deguzman1 and Erin Peckham-Gregory2, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Houston, TX

    Background/Purpose: Differences in prevalence rates of childhood-onset SLE (cSLE) among different racial/ethnic groups have been well described. Yet, the role of social determinants of health…
  • Abstract Number: 014 • 2023 Pediatric Rheumatology Symposium

    Characterizing Lupus in African American Children in Southern United States

    Anita Dhanrajani1, Taylor Long1, Spencer Hagwood2, Leslie Johnson1 and Cynthia Karlson1, 1University of Mississipi Medical Center, Jackson, MS, 2University of Mississipi Medical Center School of Medicine, Jackson, MS

    Background/Purpose: African-American (AA) ethnicity is a known predisposing factor for childhood onset systemic lupus erythematosus (cSLE) and a predictor of poor outcomes. In addition to…
  • Abstract Number: L09 • ACR Convergence 2022

    Impact on Access to Methotrexate in the Post-Roe Era

    Kristin Wipfler1, Adam Cornish1, Rebecca Schumacher2, Yomei Shaw3, Patricia Katz4 and Kaleb Michaud5, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, 3FORWARD, The National Databank for Rheumatic Diseases, Santa Fe, NM, 4UCSF, San Rafael, CA, 5University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Methotrexate is the first line therapy for RA and is used to treat several other rheumatic and non-rheumatic disorders. In high doses, it can…
  • Abstract Number: 0068 • ACR Convergence 2022

    Differential Diagnostic Coding Patterns and Associated Sociodemographic Factors in Childhood-Onset Lupus Nephritis

    Emily Smitherman1, Rouba Chahine1, Aimee Hersh2 and Jeffrey Curtis3, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Utah, Salt Lake City, UT, 3University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Disparities in long-term kidney outcomes have been documented in patients with childhood-onset systemic lupus erythematosus (cSLE) complicated by lupus nephritis (LN). However, there remains…
  • Abstract Number: 0227 • ACR Convergence 2022

    The Rheumatology Workforce: Analyzing Geographic and Temporal Variations Among the Rheumatology Physician Workforce in the United States

    Kavish Singh1, Lynn Foster-Johnson2, Sladjana Skopelja-Gardner3, Arabi Rasendrakumar4, Temitope Ajayi5 and Aakanksha Khanna6, 1Montefiore Medical Center, Brooklyn, NY, 2Dartmouth Geisel School of Medicine, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4University of Buffalo, Buffalo, NY, 5University at Buffalo, Buffalo, NY, 6Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: To analyze recent trends in the rheumatology workforce related to temporal and national geographic variation in the United States (US). Methods: The publicly available physician workforce…
  • Abstract Number: 1101 • ACR Convergence 2022

    Sex and Racial Differences in Systemic Lupus Erythematosus Among U.S. Adults in the All of Us Research Program

    Rachel Elam1, Deepak Ayyala1, Adria Madera-Acosta1, Stephen Bell1, Anam Qureshi1, Christopher Rice2, Laura Carbone1, Steven Coughlin1 and Hong Shi3, 1Augusta University, Augusta, GA, 2Moses H. Cone Memorial Hospital, Augusta, GA, 3Department of Internal Medicine/Division of Rheumatology, Vascular Biology Center, Augusta, GA

    Background/Purpose: Most persons with systemic lupus erythematosus (SLE) are women, and men with SLE are an understudied demographic. The purpose of this study was to…
  • Abstract Number: 1530 • ACR Convergence 2022

    Scleroderma Renal Crisis: Time to Initiation of Therapy Does Not Affect Mortality

    Aditi Patel1, Chao Zhang1 and Soumya Chatterjee2, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: Scleroderma renal crisis (SRC) is a rare complication in patients with systemic sclerosis (SSc), characterized by accelerated hypertension and acute kidney injury. ACE inhibitors…
  • Abstract Number: 0081 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study

    Timothy Kwok1, Bindee Kuriya1, Lauren King1, Lihi Eder2, Carter Thorne3, Zhiyin Li4, therese stukel4, longdi fu4, alexander Kopp4 and Jessica Widdifield5, 1University of Toronto, Toronto, ON, Canada, 2Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4ICES, Toronto, ON, Canada, 5Sunnybrook Research Institute, Toronto, ON, Canada

    Background/Purpose: We sought to describe changes in service delivery and access to rheumatologists in terms of changes in weekly total office visit volumes, telemedicine visits,…
  • Abstract Number: 0240 • ACR Convergence 2022

    Few and Far Between: Addressing the Pediatric Rheumatology Workforce Gap with a Spotlight on Medicine-pediatrics Residency Trained Rheumatologist Career Paths

    Kimberly DeQuattro1, Cuoghi Edens2, Connie Herndon3, Bethany Marston4 and Beth Jonas5, 1University of Pennsylvania, Philadelphia, PA, 2University of Chicago, Chicago, IL, 3American College of Rheumatology, Atlanta, GA, 4University of Rochester, Rochester, NY, 5University of North Carolina Chapel Hill, Chapel Hill, NC

    Background/Purpose: The pediatric rheumatology workforce faces a critical shortage. The recent ACR Pediatric Rheumatology Workforce Study projects that by 2030, modest expansion of the 300…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 29
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology